TLR-9 and TLR-7 stimulation of CD38 B-CLL leads to an increased numbers of cells expressing CD38 (surface protein with expression that increases upon normal B-cell activation, a marker of disease aggression in B-CLL) on sorted B-CLL cells [104]. This evidence concerns the gene TLR7 and B-cell chronic lymphocytic leukemia.